Cloned (Comment) | Organism |
---|---|
gene kmo, quantitative RT-PCR enzyme expression analysis | Sus scrofa |
gene kmo, quantitative RT-PCR enzyme expression analysis | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
mitochondrial outer membrane | - |
Sus scrofa | 5741 | - |
mitochondrial outer membrane | - |
Homo sapiens | 5741 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-kynurenine + NADPH + H+ + O2 | Sus scrofa | - |
3-hydroxy-L-kynurenine + NADP+ + H2O | - |
? | |
L-kynurenine + NADPH + H+ + O2 | Homo sapiens | - |
3-hydroxy-L-kynurenine + NADP+ + H2O | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | O15229 | - |
- |
Sus scrofa | Q9MZS9 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
kidney | high enzyme expression level | Sus scrofa | - |
kidney | high enzyme expression level | Homo sapiens | - |
Pan-T cell | peripheral blood Pan-T cells | Homo sapiens | - |
tubular epithelial cell | cortical renal TEC | Sus scrofa | - |
tubular epithelial cell | cortical renal TEC | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-kynurenine + NADPH + H+ + O2 | - |
Sus scrofa | 3-hydroxy-L-kynurenine + NADP+ + H2O | - |
? | |
L-kynurenine + NADPH + H+ + O2 | - |
Homo sapiens | 3-hydroxy-L-kynurenine + NADP+ + H2O | - |
? |
Synonyms | Comment | Organism |
---|---|---|
KMO | - |
Sus scrofa |
KMO | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
FAD | - |
Sus scrofa | |
FAD | - |
Homo sapiens | |
NADPH | - |
Sus scrofa | |
NADPH | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Sus scrofa | KMO is downregulated in autografts and is almost completely silenced in allograft rejection | down |
Homo sapiens | KMO is downregulated in autografts and is almost completely silenced in allograft rejection | down |
General Information | Comment | Organism |
---|---|---|
malfunction | KMO is downregulated in autografts and is almost completely silenced in allograft rejection | Sus scrofa |
malfunction | KMO is downregulated in autografts and is almost completely silenced in allograft rejection | Homo sapiens |
physiological function | kynurenine 3-monooxygenase (KMO) and kynureninase are reduced in ischemia-reperfusion procedure and further decreased in rejection allografts among mismatched pig KTx, molecular mechanism, overview. TEC injury in acutely rejection allografts is associated with alterations of Bcl2 family proteins, reduction of tight junction protein 1 (TJP1), and TEC-specific KMO. Three cytokines, IFNgamma, TNFalpha, and IL1beta, are identified as triggers of TEC injury by altering the expression of Bcl2, BID, and TJP1. Allograft rejection and TEC injury are always associated with a dramatic reduction of KMO. 3-Hydroxy-L-kynurenine (3HK) and hydroxyl-3 anthranilic acid (3HAA) as direct and downstream products of KMO, effectively protect TEC from injury via increasing expression of Bcl-xL and TJP1. 3HK and 3HAA effectively inhibit T cell proliferation | Sus scrofa |
physiological function | renal tubular epithelial cells (TECs) are the primary targets of ischemia-reperfusion injury (IRI) and rejection by the recipient's immune response in kidney transplantation (KTx). Kynurenine 3-monooxygenase (KMO) and kynureninase are reduced in ischemia-reperfusion procedure, molecular mechanism, overview. TEC injury in acutely rejection allografts is associated with alterations of Bcl2 family proteins, reduction of tight junction protein 1 (TJP1), and TEC-specific KMO. Three cytokines, IFNgamma, TNFalpha, and IL1beta, aere identified as triggers of TEC injury by altering the expression of Bcl2, BID, and TJP1. Allograft rejection and TEC injury are always associated with a dramatic reduction of KMO. 3-Hydroxy-L-kynurenine (3HK) and hydroxyl-3 anthranilic acid (3HAA) as direct and downstream products of KMO, effectively protect TEC from injury via increasing expression of Bcl-xL and TJP1. 3HK and 3HAA effectively inhibit T cell proliferation | Homo sapiens |